Malin Life Sciences Holdings Ltd, Ten Percent Owner Other at Poseida Therapeutics, Inc. (PSTX), bought 98,210 shares at $6.85 ($673K) on 2021-11-30, disclosed to the SEC on 2021-12-02.
Open-market purchase of $673k PSTX by Ten Percent Owner Other. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.85 | 28,592 | $196K | 29.1% |
| 2 | $6.85 | 28,592 | $196K | 29.1% |
| 3 | $6.85 | 18,365 | $126K | 18.7% |
| 4 | $6.85 | 18,365 | $126K | 18.7% |
| 5 | $6.88 | 4,296 | $30K | 4.4% |
| Total | $6.85 avg | 98,210 |
| $673K |
| 100% |
| Filing → |
| PSTX | BUY | 2021-11-29 | $531K | — | Filing → |
| PSTX | BUY | 2021-11-23 | $363K | — | Filing → |
| PSTX | BUY | 2021-11-18 | $5.5M | — | Filing → |